Product Information
IBUPROFEN-FAMOTIDIN 800-26.6 MG is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.9449 per EA under NDC 31722031590. Its NADAC has been published 142 times since Oct 11, 2023.
Strength
26.6; 800 mg/1; mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722031590
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FAMOTIDINE; IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA216814On Market Since
3/15/2023
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN-FAMOTIDIN 800-26.6 MG has been published 142 times since Oct 11, 2023, and over the history we have for it it has declined 69.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9449 per EA |
|---|---|
| All-time high | $3.1024 (Dec 13, 2023) |
| All-time low | $0.6418 (Feb 18, 2026) |
| 52-week high | $1.0292 |
| 52-week low | $0.6418 |
| Median price | $1.0234 |
| Average price | $1.3491 |
| Largest weekly change | -44.8% (Mar 20, 2024) |
| Weeks tracked | 142 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IBUPROFEN-FAMOTIDIN 800-26.6 MG?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN-FAMOTIDIN 800-26.6 MG, manufactured by Camber Pharmaceuticals Inc., is $0.9449 per EA (NDC 31722031590), effective Jun 24, 2026.
How has the price of IBUPROFEN-FAMOTIDIN 800-26.6 MG changed over time?
Over the history we have for it, the NADAC for IBUPROFEN-FAMOTIDIN 800-26.6 MG has declined 69.5%. It has been tracked across 142 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for IBUPROFEN-FAMOTIDIN 800-26.6 MG?
Since Oct 11, 2023, the NADAC for IBUPROFEN-FAMOTIDIN 800-26.6 MG has ranged from a low of $0.6418 (Feb 18, 2026) to a high of $3.1024 (Dec 13, 2023), with a median of $1.0234 per EA.
Are there cheaper alternatives to IBUPROFEN-FAMOTIDIN 800-26.6 MG?
2 NADAC-published products share the same active ingredient, strength, and dosage form as IBUPROFEN-FAMOTIDIN 800-26.6 MG, but none are currently priced below it.
Who manufactures IBUPROFEN-FAMOTIDIN 800-26.6 MG?
IBUPROFEN-FAMOTIDIN 800-26.6 MG (NDC 31722031590) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification